Offer treatment for various anemias, particularly severe aplastic anemia (SAA). Extensive experience in managing complex and rare conditions, including:

• Congenital dyserythropoietic anemia (CDA)
• Fanconi anemia
• Dyskeratosis congenita
• Iron-refractory iron deficiency anemia (IRIDA)
• Hemochromatosis

Fengkui Zhang, M.D.

Distinguished clinical expert. With extensive experience in internal medicine, specializing in hematologic disorders, with a focus on complex and severe anemias.

Jun Shi, M.D.

Deputy Director of the Institute/Hospital; Director, Regenerative Medicine Center; Director, Red Blood Cell Disorder Center; Deputy Director, National Clinical Research Center for Blood Diseases. Specializing in:

• Aplastic anemia (AA)
• Myelodysplastic syndromes (MDS)
• Hemolytic disorders, particularly relapsed/refractory autoimmune hemolytic anemia (AIHA)
• Pure red cell aplasia (PRCA) and hematopoietic dysfunction in large granular lymphocyte leukemia (LGLL)
• Isolated thrombocytopenia and isolated leukopenia
• Stem cell therapies for thalassemia